Last reviewed 2026-05-15 · How we verify

Placebo for Vitamin B compound

A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.

A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Control arm in Phase 3 trial for Vitamin B compound (specific indication unknown).

At a glance

Mechanism of action

Placebos are inert substances used as controls in clinical trials to measure the effect of an active drug against baseline or psychological expectation. In this case, it serves as a comparator arm in a Phase 3 trial evaluating a Vitamin B compound, allowing researchers to distinguish true drug efficacy from placebo response.

Approved indications

• Control arm in Phase 3 trial for Vitamin B compound (specific indication unknown)

Common side effects

No common side effects on file.

Key clinical trials

• Vitamin B Supplementation for Patients Undergoing Cardiovascular Surgery (NA)
• Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome (PHASE3)
• Psilocybin-assisted Therapy for Alcohol Use Disorder (PHASE2)
• Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults (NA)
• The Safety and Efficacy of a Compound Natural Health Product in Children With Attention Deficit Hyperactivity Disorder (ADHD) (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• Placebo for Vitamin B compound CI brief — competitive landscape report
• Placebo for Vitamin B compound updates RSS · CI watch RSS
• Wuerzburg University Hospital portfolio CI